Fuller & Thaler Asset Management’s Agilon Health AGL Stock Holding History

Fuller & Thaler Asset Management’s Portfolio AGL Stock Details AGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$885K	Buy	+8,254	New	+$541K	﹤0.01%	410

Other funds holding AGL

CDR

Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

NPCM

North Peak Capital Management New York $900M AUM 193.67% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

DCP

Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Fuller & Thaler Asset Management's AGL Position: Q2 2026 in Review

Fuller & Thaler Asset Management opened a new position in Agilon Health (AGL) in Q2 2026: 8,254 shares worth $885K. The stake represents ﹤0.01% of the portfolio and ranks #410 among its holdings.

179 funds tracked by Wall St. Rank hold AGL as of Q2 2026.

Fuller & Thaler Asset Management held 8,254 shares of Agilon Health worth $885K as of Q2 2026.
Agilon Health was a new Fuller & Thaler Asset Management position in Q2 2026.
Agilon Health made up ﹤0.01% of Fuller & Thaler Asset Management's portfolio in Q2 2026, its #410 holding.
179 funds tracked by Wall St. Rank held Agilon Health as of Q2 2026.

Based on Fuller & Thaler Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.